Work in HR? Unlock Free Profile

Haemonetics Reviews

49 Reviews
49 Reviews
Rating Trends

Recommend to a friend
Approve of CEO
Haemonetics President, CEO, and Director Brian Concannon
Brian Concannon
27 Ratings

    Growing company with great concept

    • Comp & Benefits
    • Work/Life Balance
    • Senior Management
    • Culture & Values
    • Career Opportunities
    Current Employee - Global Marketing
    Current Employee - Global Marketing

    I have been working at Haemonetics full-time


    Unique mission of end to end blood management
    Dynamic and rapidly changing
    Good sales and marketing
    Plenty of opportunities to make a difference
    Good benefits
    Challenging work
    Great people


    Poor communication within the company
    Fractured organization and management
    Weak quality and regulatory
    Good intentions, but lacks employee development

    Advice to ManagementAdvice

    Improve communication and organization. As the company grows by acquisition, it is expected that there will be some communication and organizational challenges, but it could be better than it is.

    Neutral Outlook
    Approves of CEO

Haemonetics Interviews

Interview Experience

Interview Experience


Getting an Interview

Getting an Interview


Interview Difficulty


Interview Difficulty




    Regulatory Affairs Specialist Interview

    Anonymous Interview Candidate  in  Braintree, MA
    Anonymous Interview Candidate in Braintree, MA
    Application Details

    I applied in-person - interviewed at Haemonetics in April 2012.

    Interview Details

    1. Interview one on one
    2. 15 minute talent screening test
    3. Company round

    Interview Questions
    Accepted Offer
    Positive Experience
    Easy Interview

Haemonetics Awards & Accolades

Something missing? Add an award
America's 200 Best Small Companies, Forbes, 2009
America's 200 Best Small Companies, Forbes, 2008

Additional Info

Unlock Profile
Website www.haemonetics.com
Headquarters Braintree, MA
Size 1000 to 5000 Employees
Founded 1971
Type Company - Public (HAE)
Industry Manufacturing
Revenue $500 million to $1 billion (USD) per year

Haemonetics helps health care providers keep track of blood. The company develops and produces automated blood collection systems that collect and process whole blood, taking only the components (such as plasma or red blood cells) needed and returning the remainder to the donors. Typically these systems, sold under the Cymbal or MCS brands, are bought and used by blood centers. Haemonetics also makes hospital systems that collect and re-infuse a patient's own blood during surgery; these surgical blood salvage systems are sold under the cardioPAT and Cell Saver brand names... More

Worked for Haemonetics? Contribute to the Community!